Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Rallybio (RLYB) EBIT Margin (2024 - 2025)

Historic EBIT Margin for Rallybio (RLYB) over the last 2 years, with Q3 2025 value amounting to 3266.51%.

  • Rallybio's EBIT Margin rose 7689400.0% to 3266.51% in Q3 2025 from the same period last year, while for Sep 2025 it was 5996.87%, marking a year-over-year increase of 57088200.0%. This contributed to the annual value of 10082.67% for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Rallybio's EBIT Margin is 3266.51%, which was up 7689400.0% from 4743.87% recorded in Q2 2025.
  • Rallybio's EBIT Margin's 5-year high stood at 3266.51% during Q3 2025, with a 5-year trough of 580400.0% in Q4 2024.